ArticleImmunotherapy advances2025

Lung immune challenge study protocol: controlled exposure to inhaled resiquimod (R848) to study mechanisms of inflammation.

Akhilesh Jha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.